EHC Stock Recent News
EHC LATEST HEADLINES
Encompass Health (EHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Company will award research-funding grants totaling up to $60,000 BIRMINGHAM, Ala. , May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BIRMINGHAM, Ala. , May 1, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on July 15, 2025, to holders of record on July 1, 2025.
BIRMINGHAM, Ala. , April 28, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2025 Healthcare Conference, which is being held May 13-15, 2025.
EHC's Q1 results benefit on the back of discharge growth and expansion endeavors, partly offset by high operating costs. It currently expects 2025 adjusted EPS from continuing operations within $4.85-$5.10.
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Encompass Health Corporation (NYSE:EHC ) Q1 2025 Earnings Conference Call April 25, 2025 9:00 AM ET Corporate Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Douglas Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Whit Mayo - Leerink Partners Matthew Gillmor - KeyBanc Capital Markets Ann Hynes - Mizuho Securities Joanna Gajuk - BofA Securities Brian Tanquilut - Jefferies A.J. Rice - UBS Jared Haase - William Blair Andrew Mok - Barclays John Ransom - Raymond James Operator Good morning, everyone, and welcome to Encompass Health's First Quarter 2025 Earnings Conference Call.